Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Icos patents new potent and selective PDE4 inhibitors

Aug. 20, 2001

Flavonoid consumption associated with reduced incidence of COPD

Aug. 20, 2001

Phase I trial initiated for Inspire's sinusitis therapy

Aug. 20, 2001

INOmax approved in Europe for treating critically ill newborns

Aug. 14, 2001

NK1 antagonists useful for treating asthma and allergic rhinitis reported by UCB

Aug. 13, 2001

EMEA awards orphan product status to Surfaxin for MAS

Aug. 13, 2001

Companies form strategic agreement to develop asthma and allergic rhinitis products

Aug. 10, 2001

Oxadiazolin-2-ones with elastase inhibitory activity reported by Ono Pharmaceuticals

Aug. 7, 2001

ZD-6021, AstraZeneca's tachykinin receptor antagonist, characterized

Aug. 6, 2001

Compounds useful for the treatment of chronic inflammatory diseases patented by F. Hoffmann-La Roche

Aug. 3, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
GWAS identifies variant associated with diabetic retinopathy and susceptibility to T2D
BioWorld Science
Scientists at the University of Nottingham Ningbo China and collaborators aimed to identify genetic variants associated with diabetic retinopathy.